Skip to Content
Merck
  • Improvement of central visual function following steroid pulse therapy in acute zonal occult outer retinopathy.

Improvement of central visual function following steroid pulse therapy in acute zonal occult outer retinopathy.

Documenta ophthalmologica. Advances in ophthalmology (2012-03-10)
Takaaki Kitakawa, Takaaki Hayashi, Hirotsugu Takashina, Katsuya Mitooka, Tamaki Gekka, Hiroshi Tsuneoka
ABSTRACT

The purpose of this study was to report a patient with acute zonal occult outer retinopathy (AZOOR) unilaterally, who received steroid pulse therapy. A 42-year-old woman presented with photopsias and severe vision loss in her left eye. Visual acuity was 0.04, and Humphrey visual field testing showed overall depression with a mean deviation (MD) value of -25.78 dB in the left eye. Fundus and angiographic examinations found no specific abnormal findings, leading to a diagnosis of AZOOR. Optical coherence tomography showed attenuation of the photoreceptor inner segment/outer segment junction (IS/OS) line. Focal macular electroretinography (fmERG) demonstrated that there were non-detectable responses at 5°, 10° and 15° (in diameter). Following steroid pulse therapy, her visual acuity was 1.0, her MD value improved to -16.08 dB, and there were both partial recovery of the IS/OS line and apparent improvements of fmERG responses (at 10° and 15°). The present findings suggest that steroid pulse therapy might potentially be an effective treatment in some AZOOR patients.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
6α-Methylprednisolone 21-hemisuccinate sodium salt, lyophilized powder